Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction-Reference-Cited by-同舟云学术

Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction

Published:2019-07-31 Issue:10 Volume:23 Page:6666-6678
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J Cell Mol Med

Author:

Brandt Maarten M.¹²^ORCID,Nguyen Isabel T. N.²,Krebber Merle M.²,Wouw Jens¹^ORCID,Mokry Michal³⁴,Cramer Maarten J.⁵,Duncker Dirk J.¹^ORCID,Verhaar Marianne C.²,Joles Jaap A.²,Cheng Caroline¹²

Affiliation:

1. Experimental Cardiology, Department of Cardiology Thoraxcenter Erasmus University Medical Center Rotterdam The Netherlands

2. Department of Nephrology and Hypertension University Medical Center Utrecht Utrecht The Netherlands

3. Epigenomics facility University Medical Center Utrecht Utrecht The Netherlands

4. Regenerative Medicine Center Utrecht University Medical Center Utrecht Utrecht The Netherlands

5. Department of Cardiology University Medical Center Utrecht Utrecht The Netherlands

Funder

Universiteit Utrecht

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.14542

Reference52 articles.

1. Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment

2. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

3. Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction

4. Epidemiology of Heart Failure with Preserved Ejection Fraction

5. Chronic angiotensin-(1–7) prevents cardiac fibrosis in DOCA-salt model of hypertension

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors and sex differences associated with intermediate probability of heart failure with preserved ejection fraction in asymptomatic patients working in the Arctic;Russian Journal of Cardiology;2023-09-21

2. Myocardial Metabolic Reprogramming in HFpEF;Journal of Cardiovascular Translational Research;2023-08-31

3. Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery;Acta Pharmacologica Sinica;2023-08-29

4. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats;American Journal of Physiology-Renal Physiology;2023-07-01

5. Factors associated with the intermediate probability of heart failure with preserved ejection fraction on the H<sub>2</sub>FPEF score in asymptomatic patients in rotation work conditions in the Arctic;Cardiovascular Therapy and Prevention;2022-07-06